Please assess the completion status of the following clinical trial:

Trial Title: Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects of 18 years of age or older~* Subjects must belong to one of this group: Rheumatoid Arthritis (RA) Subjects OR Psoriatic Arthritis (PsA) Subjects OR Spondylarthritis (SpA) Subjects~Exclusion Criteria:~* Subjects diagnosed with other autoimmune/inflammatory diseases other than Crohn's disease, psoriasis, uveitis, Sjögren's syndrome and auto-immune thyroiditis~* Subjects with an active cancer and currently receiving a cancer treatment~* Women with known pregnancy~* Breastfeeding women~* Subjects with a known history of HIV and/or Hepatitis B and/or Hepatitis C infection and/or positive for HBs antigens

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rheumatoid Arthritis (Type: None): Patients with Rheumatoid Arthritis
- Psoriatic Arthritis (Type: None): Patients with Psoriatic Arthritis
- Spondylarthritis (Type: None): Patients with Spondylarthritis

Based on this trial design, predict the completion outcome and termination type (if applicable).